Clinical Trials Browser

Phase 1 × INDUSTRY × ZD4054 × Clear all

NCT00314782 2013-03-12

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

Phase 1 Completed

Prostatic Neoplasms

NCT00997945 2011-05-19

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

Phase 1 Completed

Advanced Solid Malignancies